nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—ABCB1—ovarian cancer	0.4	1	CbGaD
Telaprevir—ABCB1—Topotecan—ovarian cancer	0.056	0.221	CbGbCtD
Telaprevir—ABCB1—Vinorelbine—ovarian cancer	0.0395	0.156	CbGbCtD
Telaprevir—CYP3A4—Topotecan—ovarian cancer	0.0336	0.133	CbGbCtD
Telaprevir—ABCB1—Paclitaxel—ovarian cancer	0.0277	0.11	CbGbCtD
Telaprevir—CYP3A4—Vinorelbine—ovarian cancer	0.0237	0.0935	CbGbCtD
Telaprevir—ABCB1—Docetaxel—ovarian cancer	0.0201	0.0792	CbGbCtD
Telaprevir—CYP3A4—Paclitaxel—ovarian cancer	0.0166	0.0657	CbGbCtD
Telaprevir—ABCB1—Doxorubicin—ovarian cancer	0.015	0.0591	CbGbCtD
Telaprevir—CYP3A4—Docetaxel—ovarian cancer	0.012	0.0475	CbGbCtD
Telaprevir—CYP3A4—Doxorubicin—ovarian cancer	0.00896	0.0354	CbGbCtD
Telaprevir—CTSK—myometrium—ovarian cancer	0.00537	0.0492	CbGeAlD
Telaprevir—CMA1—female reproductive system—ovarian cancer	0.00486	0.0445	CbGeAlD
Telaprevir—CTSS—myometrium—ovarian cancer	0.0047	0.0431	CbGeAlD
Telaprevir—CMA1—bone marrow—ovarian cancer	0.00458	0.042	CbGeAlD
Telaprevir—CTSS—embryo—ovarian cancer	0.00452	0.0415	CbGeAlD
Telaprevir—CTSK—uterine cervix—ovarian cancer	0.00418	0.0383	CbGeAlD
Telaprevir—CTSK—decidua—ovarian cancer	0.00398	0.0365	CbGeAlD
Telaprevir—CTSK—endometrium—ovarian cancer	0.00378	0.0346	CbGeAlD
Telaprevir—CTSS—uterine cervix—ovarian cancer	0.00366	0.0335	CbGeAlD
Telaprevir—CTSK—gonad—ovarian cancer	0.0035	0.0321	CbGeAlD
Telaprevir—CTSS—decidua—ovarian cancer	0.00349	0.032	CbGeAlD
Telaprevir—CTSK—uterus—ovarian cancer	0.00348	0.0319	CbGeAlD
Telaprevir—CTSS—endometrium—ovarian cancer	0.00331	0.0303	CbGeAlD
Telaprevir—CTSK—female reproductive system—ovarian cancer	0.00313	0.0287	CbGeAlD
Telaprevir—CTSS—gonad—ovarian cancer	0.00307	0.0281	CbGeAlD
Telaprevir—CTSS—uterus—ovarian cancer	0.00305	0.028	CbGeAlD
Telaprevir—CTSK—bone marrow—ovarian cancer	0.00295	0.0271	CbGeAlD
Telaprevir—CTSK—female gonad—ovarian cancer	0.00285	0.0261	CbGeAlD
Telaprevir—CMA1—lymph node—ovarian cancer	0.00284	0.026	CbGeAlD
Telaprevir—Boceprevir—ABCB1—ovarian cancer	0.00283	1	CrCbGaD
Telaprevir—CTSK—vagina—ovarian cancer	0.00283	0.0259	CbGeAlD
Telaprevir—CTSS—female reproductive system—ovarian cancer	0.00274	0.0251	CbGeAlD
Telaprevir—CTSS—bone marrow—ovarian cancer	0.00259	0.0237	CbGeAlD
Telaprevir—CTSK—testis—ovarian cancer	0.00253	0.0231	CbGeAlD
Telaprevir—CTSS—female gonad—ovarian cancer	0.0025	0.0229	CbGeAlD
Telaprevir—CTSS—vagina—ovarian cancer	0.00248	0.0227	CbGeAlD
Telaprevir—CTSS—testis—ovarian cancer	0.00221	0.0203	CbGeAlD
Telaprevir—ORM1—endometrium—ovarian cancer	0.00198	0.0181	CbGeAlD
Telaprevir—CTSK—lymph node—ovarian cancer	0.00183	0.0168	CbGeAlD
Telaprevir—Fatigue—Altretamine—ovarian cancer	0.00177	0.011	CcSEcCtD
Telaprevir—Lymphopenia—Docetaxel—ovarian cancer	0.00173	0.0108	CcSEcCtD
Telaprevir—Oral candidiasis—Paclitaxel—ovarian cancer	0.00165	0.0102	CcSEcCtD
Telaprevir—ORM1—female reproductive system—ovarian cancer	0.00164	0.015	CbGeAlD
Telaprevir—Renal failure acute—Chlorambucil—ovarian cancer	0.0016	0.00998	CcSEcCtD
Telaprevir—CTSS—lymph node—ovarian cancer	0.0016	0.0147	CbGeAlD
Telaprevir—ORM1—bone marrow—ovarian cancer	0.00155	0.0142	CbGeAlD
Telaprevir—Haemorrhoids—Docetaxel—ovarian cancer	0.00151	0.00938	CcSEcCtD
Telaprevir—Asthenia—Altretamine—ovarian cancer	0.00147	0.00915	CcSEcCtD
Telaprevir—Infection—Carboplatin—ovarian cancer	0.00141	0.00875	CcSEcCtD
Telaprevir—Renal failure acute—Melphalan—ovarian cancer	0.0014	0.0087	CcSEcCtD
Telaprevir—Oral candidiasis—Docetaxel—ovarian cancer	0.00139	0.00868	CcSEcCtD
Telaprevir—Dizziness—Altretamine—ovarian cancer	0.00135	0.00843	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Chlorambucil—ovarian cancer	0.00133	0.0083	CcSEcCtD
Telaprevir—Vomiting—Altretamine—ovarian cancer	0.0013	0.0081	CcSEcCtD
Telaprevir—Proctalgia—Epirubicin—ovarian cancer	0.00127	0.00793	CcSEcCtD
Telaprevir—Nausea—Altretamine—ovarian cancer	0.00122	0.00757	CcSEcCtD
Telaprevir—Proctalgia—Doxorubicin—ovarian cancer	0.00118	0.00734	CcSEcCtD
Telaprevir—Lymphopenia—Epirubicin—ovarian cancer	0.00117	0.00727	CcSEcCtD
Telaprevir—ALB—testis—ovarian cancer	0.00116	0.0106	CbGeAlD
Telaprevir—Rectal haemorrhage—Paclitaxel—ovarian cancer	0.00116	0.0072	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Paclitaxel—ovarian cancer	0.00115	0.00715	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Chlorambucil—ovarian cancer	0.00113	0.00704	CcSEcCtD
Telaprevir—Anorectal discomfort—Epirubicin—ovarian cancer	0.00109	0.0068	CcSEcCtD
Telaprevir—Lymphopenia—Doxorubicin—ovarian cancer	0.00108	0.00672	CcSEcCtD
Telaprevir—Blood creatinine increased—Vinorelbine—ovarian cancer	0.00106	0.00658	CcSEcCtD
Telaprevir—Infestation NOS—Topotecan—ovarian cancer	0.00102	0.00632	CcSEcCtD
Telaprevir—Infestation—Topotecan—ovarian cancer	0.00102	0.00632	CcSEcCtD
Telaprevir—Anorectal discomfort—Doxorubicin—ovarian cancer	0.00101	0.00629	CcSEcCtD
Telaprevir—Candida infection—Paclitaxel—ovarian cancer	0.000998	0.00621	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Docetaxel—ovarian cancer	0.000974	0.00606	CcSEcCtD
Telaprevir—Erythema multiforme—Chlorambucil—ovarian cancer	0.000969	0.00603	CcSEcCtD
Telaprevir—Hepatobiliary disease—Topotecan—ovarian cancer	0.000961	0.00598	CcSEcCtD
Telaprevir—ORM1—lymph node—ovarian cancer	0.000958	0.00878	CbGeAlD
Telaprevir—Hepatobiliary disease—Melphalan—ovarian cancer	0.000941	0.00586	CcSEcCtD
Telaprevir—Oral candidiasis—Epirubicin—ovarian cancer	0.000941	0.00585	CcSEcCtD
Telaprevir—Urinary tract disorder—Melphalan—ovarian cancer	0.000882	0.00549	CcSEcCtD
Telaprevir—Urethral disorder—Melphalan—ovarian cancer	0.000876	0.00545	CcSEcCtD
Telaprevir—Oral candidiasis—Doxorubicin—ovarian cancer	0.00087	0.00542	CcSEcCtD
Telaprevir—Infestation NOS—Vinorelbine—ovarian cancer	0.000869	0.00541	CcSEcCtD
Telaprevir—Infestation—Vinorelbine—ovarian cancer	0.000869	0.00541	CcSEcCtD
Telaprevir—Candida infection—Docetaxel—ovarian cancer	0.000846	0.00526	CcSEcCtD
Telaprevir—ALB—lymph node—ovarian cancer	0.00084	0.0077	CbGeAlD
Telaprevir—ABCB1—myometrium—ovarian cancer	0.00083	0.0076	CbGeAlD
Telaprevir—Anaemia—Chlorambucil—ovarian cancer	0.000824	0.00513	CcSEcCtD
Telaprevir—Hepatobiliary disease—Vinorelbine—ovarian cancer	0.000822	0.00512	CcSEcCtD
Telaprevir—Renal failure acute—Paclitaxel—ovarian cancer	0.000822	0.00511	CcSEcCtD
Telaprevir—ABCB1—embryo—ovarian cancer	0.000798	0.00731	CbGeAlD
Telaprevir—Malnutrition—Topotecan—ovarian cancer	0.000794	0.00494	CcSEcCtD
Telaprevir—Anaemia—Topotecan—ovarian cancer	0.000734	0.00457	CcSEcCtD
Telaprevir—Infection—Chlorambucil—ovarian cancer	0.000723	0.0045	CcSEcCtD
Telaprevir—Anaemia—Melphalan—ovarian cancer	0.000719	0.00447	CcSEcCtD
Telaprevir—Thrombocytopenia—Chlorambucil—ovarian cancer	0.000713	0.00444	CcSEcCtD
Telaprevir—Blood creatinine increased—Paclitaxel—ovarian cancer	0.000711	0.00442	CcSEcCtD
Telaprevir—Hypokalaemia—Paclitaxel—ovarian cancer	0.00069	0.0043	CcSEcCtD
Telaprevir—CYP3A4—female reproductive system—ovarian cancer	0.000683	0.00626	CbGeAlD
Telaprevir—Toxic epidermal necrolysis—Paclitaxel—ovarian cancer	0.000683	0.00425	CcSEcCtD
Telaprevir—Malnutrition—Vinorelbine—ovarian cancer	0.000679	0.00423	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Topotecan—ovarian cancer	0.000671	0.00418	CcSEcCtD
Telaprevir—Rectal haemorrhage—Epirubicin—ovarian cancer	0.000662	0.00412	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Melphalan—ovarian cancer	0.000657	0.00409	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Epirubicin—ovarian cancer	0.000657	0.00409	CcSEcCtD
Telaprevir—ABCB1—epithelium—ovarian cancer	0.000651	0.00597	CbGeAlD
Telaprevir—ABCB1—uterine cervix—ovarian cancer	0.000646	0.00592	CbGeAlD
Telaprevir—Hyperuricaemia—Epirubicin—ovarian cancer	0.000644	0.00401	CcSEcCtD
Telaprevir—Infection—Topotecan—ovarian cancer	0.000644	0.00401	CcSEcCtD
Telaprevir—Nervous system disorder—Topotecan—ovarian cancer	0.000636	0.00396	CcSEcCtD
Telaprevir—Thrombocytopenia—Topotecan—ovarian cancer	0.000635	0.00395	CcSEcCtD
Telaprevir—Infection—Melphalan—ovarian cancer	0.00063	0.00392	CcSEcCtD
Telaprevir—Skin disorder—Topotecan—ovarian cancer	0.000629	0.00392	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Chlorambucil—ovarian cancer	0.000628	0.00391	CcSEcCtD
Telaprevir—Anaemia—Vinorelbine—ovarian cancer	0.000628	0.00391	CcSEcCtD
Telaprevir—Fatigue—Chlorambucil—ovarian cancer	0.000628	0.00391	CcSEcCtD
Telaprevir—Thrombocytopenia—Melphalan—ovarian cancer	0.000621	0.00387	CcSEcCtD
Telaprevir—Skin disorder—Melphalan—ovarian cancer	0.000616	0.00384	CcSEcCtD
Telaprevir—ABCB1—decidua—ovarian cancer	0.000615	0.00564	CbGeAlD
Telaprevir—Rectal haemorrhage—Doxorubicin—ovarian cancer	0.000612	0.00381	CcSEcCtD
Telaprevir—Blood uric acid increased—Epirubicin—ovarian cancer	0.000608	0.00379	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Doxorubicin—ovarian cancer	0.000608	0.00378	CcSEcCtD
Telaprevir—Hyperuricaemia—Doxorubicin—ovarian cancer	0.000596	0.00371	CcSEcCtD
Telaprevir—Infestation NOS—Paclitaxel—ovarian cancer	0.000585	0.00364	CcSEcCtD
Telaprevir—Infestation—Paclitaxel—ovarian cancer	0.000585	0.00364	CcSEcCtD
Telaprevir—ABCB1—endometrium—ovarian cancer	0.000584	0.00535	CbGeAlD
Telaprevir—Stevens-Johnson syndrome—Paclitaxel—ovarian cancer	0.00058	0.00361	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Docetaxel—ovarian cancer	0.000579	0.0036	CcSEcCtD
Telaprevir—Urticaria—Chlorambucil—ovarian cancer	0.000578	0.0036	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—ovarian cancer	0.000574	0.00357	CcSEcCtD
Telaprevir—Candida infection—Epirubicin—ovarian cancer	0.00057	0.00355	CcSEcCtD
Telaprevir—Blood uric acid increased—Doxorubicin—ovarian cancer	0.000563	0.0035	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Topotecan—ovarian cancer	0.000559	0.00348	CcSEcCtD
Telaprevir—Fatigue—Topotecan—ovarian cancer	0.000559	0.00348	CcSEcCtD
Telaprevir—Hepatobiliary disease—Paclitaxel—ovarian cancer	0.000553	0.00344	CcSEcCtD
Telaprevir—Infection—Vinorelbine—ovarian cancer	0.000551	0.00343	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Melphalan—ovarian cancer	0.000548	0.00341	CcSEcCtD
Telaprevir—Fatigue—Melphalan—ovarian cancer	0.000547	0.0034	CcSEcCtD
Telaprevir—Nervous system disorder—Vinorelbine—ovarian cancer	0.000544	0.00338	CcSEcCtD
Telaprevir—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000543	0.00338	CcSEcCtD
Telaprevir—ABCB1—gonad—ovarian cancer	0.000542	0.00496	CbGeAlD
Telaprevir—Skin disorder—Vinorelbine—ovarian cancer	0.000538	0.00335	CcSEcCtD
Telaprevir—ABCB1—uterus—ovarian cancer	0.000538	0.00493	CbGeAlD
Telaprevir—Candida infection—Doxorubicin—ovarian cancer	0.000528	0.00328	CcSEcCtD
Telaprevir—Asthenia—Chlorambucil—ovarian cancer	0.000522	0.00325	CcSEcCtD
Telaprevir—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000518	0.00323	CcSEcCtD
Telaprevir—Oedema peripheral—Paclitaxel—ovarian cancer	0.000517	0.00322	CcSEcCtD
Telaprevir—Pruritus—Chlorambucil—ovarian cancer	0.000515	0.00321	CcSEcCtD
Telaprevir—Urticaria—Topotecan—ovarian cancer	0.000515	0.0032	CcSEcCtD
Telaprevir—Urethral disorder—Paclitaxel—ovarian cancer	0.000514	0.0032	CcSEcCtD
Telaprevir—Urticaria—Melphalan—ovarian cancer	0.000504	0.00314	CcSEcCtD
Telaprevir—Diarrhoea—Chlorambucil—ovarian cancer	0.000498	0.0031	CcSEcCtD
Telaprevir—Erythema multiforme—Paclitaxel—ovarian cancer	0.000496	0.00309	CcSEcCtD
Telaprevir—Infestation—Docetaxel—ovarian cancer	0.000496	0.00308	CcSEcCtD
Telaprevir—Infestation NOS—Docetaxel—ovarian cancer	0.000496	0.00308	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.000491	0.00306	CcSEcCtD
Telaprevir—Eye disorder—Paclitaxel—ovarian cancer	0.00049	0.00305	CcSEcCtD
Telaprevir—ABCB1—female reproductive system—ovarian cancer	0.000484	0.00443	CbGeAlD
Telaprevir—Eczema—Epirubicin—ovarian cancer	0.000483	0.003	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000479	0.00298	CcSEcCtD
Telaprevir—Fatigue—Vinorelbine—ovarian cancer	0.000478	0.00297	CcSEcCtD
Telaprevir—Renal failure acute—Epirubicin—ovarian cancer	0.00047	0.00292	CcSEcCtD
Telaprevir—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000469	0.00292	CcSEcCtD
Telaprevir—Asthenia—Topotecan—ovarian cancer	0.000465	0.00289	CcSEcCtD
Telaprevir—Vomiting—Chlorambucil—ovarian cancer	0.000463	0.00288	CcSEcCtD
Telaprevir—Pruritus—Topotecan—ovarian cancer	0.000458	0.00285	CcSEcCtD
Telaprevir—Malnutrition—Paclitaxel—ovarian cancer	0.000457	0.00284	CcSEcCtD
Telaprevir—ABCB1—bone marrow—ovarian cancer	0.000457	0.00419	CbGeAlD
Telaprevir—Asthenia—Melphalan—ovarian cancer	0.000455	0.00283	CcSEcCtD
Telaprevir—Pruritus—Melphalan—ovarian cancer	0.000449	0.00279	CcSEcCtD
Telaprevir—Dysgeusia—Paclitaxel—ovarian cancer	0.000447	0.00278	CcSEcCtD
Telaprevir—Eczema—Doxorubicin—ovarian cancer	0.000447	0.00278	CcSEcCtD
Telaprevir—Diarrhoea—Topotecan—ovarian cancer	0.000443	0.00276	CcSEcCtD
Telaprevir—Urticaria—Vinorelbine—ovarian cancer	0.00044	0.00274	CcSEcCtD
Telaprevir—ABCB1—female gonad—ovarian cancer	0.00044	0.00403	CbGeAlD
Telaprevir—Urinary tract disorder—Docetaxel—ovarian cancer	0.000439	0.00273	CcSEcCtD
Telaprevir—Oedema peripheral—Docetaxel—ovarian cancer	0.000438	0.00273	CcSEcCtD
Telaprevir—ABCB1—vagina—ovarian cancer	0.000438	0.00401	CbGeAlD
Telaprevir—Urethral disorder—Docetaxel—ovarian cancer	0.000436	0.00271	CcSEcCtD
Telaprevir—Renal failure acute—Doxorubicin—ovarian cancer	0.000435	0.00271	CcSEcCtD
Telaprevir—Diarrhoea—Melphalan—ovarian cancer	0.000434	0.0027	CcSEcCtD
Telaprevir—Nausea—Chlorambucil—ovarian cancer	0.000432	0.00269	CcSEcCtD
Telaprevir—Dizziness—Topotecan—ovarian cancer	0.000429	0.00267	CcSEcCtD
Telaprevir—Anaemia—Paclitaxel—ovarian cancer	0.000422	0.00263	CcSEcCtD
Telaprevir—Erythema multiforme—Docetaxel—ovarian cancer	0.000421	0.00262	CcSEcCtD
Telaprevir—Eye disorder—Docetaxel—ovarian cancer	0.000416	0.00259	CcSEcCtD
Telaprevir—Vomiting—Topotecan—ovarian cancer	0.000412	0.00256	CcSEcCtD
Telaprevir—Syncope—Paclitaxel—ovarian cancer	0.00041	0.00255	CcSEcCtD
Telaprevir—Rash—Topotecan—ovarian cancer	0.000409	0.00254	CcSEcCtD
Telaprevir—Dermatitis—Topotecan—ovarian cancer	0.000408	0.00254	CcSEcCtD
Telaprevir—Blood creatinine increased—Epirubicin—ovarian cancer	0.000406	0.00253	CcSEcCtD
Telaprevir—Vomiting—Melphalan—ovarian cancer	0.000403	0.00251	CcSEcCtD
Telaprevir—Loss of consciousness—Paclitaxel—ovarian cancer	0.000402	0.0025	CcSEcCtD
Telaprevir—Rash—Melphalan—ovarian cancer	0.0004	0.00249	CcSEcCtD
Telaprevir—Dermatitis—Melphalan—ovarian cancer	0.0004	0.00249	CcSEcCtD
Telaprevir—Asthenia—Vinorelbine—ovarian cancer	0.000398	0.00248	CcSEcCtD
Telaprevir—Hypokalaemia—Epirubicin—ovarian cancer	0.000395	0.00246	CcSEcCtD
Telaprevir—Pruritus—Vinorelbine—ovarian cancer	0.000392	0.00244	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000391	0.00243	CcSEcCtD
Telaprevir—ABCB1—testis—ovarian cancer	0.00039	0.00358	CbGeAlD
Telaprevir—Malnutrition—Docetaxel—ovarian cancer	0.000387	0.00241	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000386	0.0024	CcSEcCtD
Telaprevir—Nausea—Topotecan—ovarian cancer	0.000385	0.0024	CcSEcCtD
Telaprevir—Diarrhoea—Vinorelbine—ovarian cancer	0.000379	0.00236	CcSEcCtD
Telaprevir—Dysgeusia—Docetaxel—ovarian cancer	0.000379	0.00236	CcSEcCtD
Telaprevir—Nausea—Melphalan—ovarian cancer	0.000377	0.00235	CcSEcCtD
Telaprevir—Blood creatinine increased—Doxorubicin—ovarian cancer	0.000376	0.00234	CcSEcCtD
Telaprevir—Eosinophilia—Epirubicin—ovarian cancer	0.000371	0.00231	CcSEcCtD
Telaprevir—Infection—Paclitaxel—ovarian cancer	0.00037	0.00231	CcSEcCtD
Telaprevir—Shock—Paclitaxel—ovarian cancer	0.000367	0.00228	CcSEcCtD
Telaprevir—Dizziness—Vinorelbine—ovarian cancer	0.000367	0.00228	CcSEcCtD
Telaprevir—Nervous system disorder—Paclitaxel—ovarian cancer	0.000366	0.00228	CcSEcCtD
Telaprevir—Hypokalaemia—Doxorubicin—ovarian cancer	0.000365	0.00227	CcSEcCtD
Telaprevir—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000365	0.00227	CcSEcCtD
Telaprevir—Skin disorder—Paclitaxel—ovarian cancer	0.000362	0.00225	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000361	0.00225	CcSEcCtD
Telaprevir—Anaemia—Docetaxel—ovarian cancer	0.000358	0.00223	CcSEcCtD
Telaprevir—Vomiting—Vinorelbine—ovarian cancer	0.000352	0.00219	CcSEcCtD
Telaprevir—Rash—Vinorelbine—ovarian cancer	0.00035	0.00218	CcSEcCtD
Telaprevir—Dermatitis—Vinorelbine—ovarian cancer	0.000349	0.00217	CcSEcCtD
Telaprevir—Syncope—Docetaxel—ovarian cancer	0.000347	0.00216	CcSEcCtD
Telaprevir—Eosinophilia—Doxorubicin—ovarian cancer	0.000343	0.00214	CcSEcCtD
Telaprevir—Loss of consciousness—Docetaxel—ovarian cancer	0.00034	0.00212	CcSEcCtD
Telaprevir—Infestation—Epirubicin—ovarian cancer	0.000334	0.00208	CcSEcCtD
Telaprevir—Infestation NOS—Epirubicin—ovarian cancer	0.000334	0.00208	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000331	0.00206	CcSEcCtD
Telaprevir—Nausea—Vinorelbine—ovarian cancer	0.000329	0.00205	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000327	0.00204	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000322	0.002	CcSEcCtD
Telaprevir—Fatigue—Paclitaxel—ovarian cancer	0.000321	0.002	CcSEcCtD
Telaprevir—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000316	0.00197	CcSEcCtD
Telaprevir—Infection—Docetaxel—ovarian cancer	0.000314	0.00195	CcSEcCtD
Telaprevir—Shock—Docetaxel—ovarian cancer	0.000311	0.00194	CcSEcCtD
Telaprevir—Nervous system disorder—Docetaxel—ovarian cancer	0.00031	0.00193	CcSEcCtD
Telaprevir—Thrombocytopenia—Docetaxel—ovarian cancer	0.000309	0.00193	CcSEcCtD
Telaprevir—Infestation—Doxorubicin—ovarian cancer	0.000309	0.00192	CcSEcCtD
Telaprevir—Infestation NOS—Doxorubicin—ovarian cancer	0.000309	0.00192	CcSEcCtD
Telaprevir—Skin disorder—Docetaxel—ovarian cancer	0.000307	0.00191	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000307	0.00191	CcSEcCtD
Telaprevir—Urinary tract disorder—Epirubicin—ovarian cancer	0.000296	0.00184	CcSEcCtD
Telaprevir—Urticaria—Paclitaxel—ovarian cancer	0.000296	0.00184	CcSEcCtD
Telaprevir—Oedema peripheral—Epirubicin—ovarian cancer	0.000296	0.00184	CcSEcCtD
Telaprevir—Urethral disorder—Epirubicin—ovarian cancer	0.000294	0.00183	CcSEcCtD
Telaprevir—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000292	0.00182	CcSEcCtD
Telaprevir—Erythema multiforme—Epirubicin—ovarian cancer	0.000284	0.00177	CcSEcCtD
Telaprevir—ABCB1—lymph node—ovarian cancer	0.000283	0.00259	CbGeAlD
Telaprevir—Eye disorder—Epirubicin—ovarian cancer	0.00028	0.00175	CcSEcCtD
Telaprevir—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000274	0.00171	CcSEcCtD
Telaprevir—Oedema peripheral—Doxorubicin—ovarian cancer	0.000274	0.0017	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000273	0.0017	CcSEcCtD
Telaprevir—Fatigue—Docetaxel—ovarian cancer	0.000272	0.0017	CcSEcCtD
Telaprevir—Urethral disorder—Doxorubicin—ovarian cancer	0.000272	0.00169	CcSEcCtD
Telaprevir—Asthenia—Paclitaxel—ovarian cancer	0.000268	0.00166	CcSEcCtD
Telaprevir—Pruritus—Paclitaxel—ovarian cancer	0.000264	0.00164	CcSEcCtD
Telaprevir—Erythema multiforme—Doxorubicin—ovarian cancer	0.000263	0.00163	CcSEcCtD
Telaprevir—Malnutrition—Epirubicin—ovarian cancer	0.000261	0.00163	CcSEcCtD
Telaprevir—Eye disorder—Doxorubicin—ovarian cancer	0.000259	0.00161	CcSEcCtD
Telaprevir—Dysgeusia—Epirubicin—ovarian cancer	0.000256	0.00159	CcSEcCtD
Telaprevir—Diarrhoea—Paclitaxel—ovarian cancer	0.000255	0.00159	CcSEcCtD
Telaprevir—Dizziness—Paclitaxel—ovarian cancer	0.000247	0.00153	CcSEcCtD
Telaprevir—Malnutrition—Doxorubicin—ovarian cancer	0.000242	0.0015	CcSEcCtD
Telaprevir—Anaemia—Epirubicin—ovarian cancer	0.000241	0.0015	CcSEcCtD
Telaprevir—Vomiting—Paclitaxel—ovarian cancer	0.000237	0.00148	CcSEcCtD
Telaprevir—Dysgeusia—Doxorubicin—ovarian cancer	0.000237	0.00147	CcSEcCtD
Telaprevir—Rash—Paclitaxel—ovarian cancer	0.000235	0.00146	CcSEcCtD
Telaprevir—Dermatitis—Paclitaxel—ovarian cancer	0.000235	0.00146	CcSEcCtD
Telaprevir—Syncope—Epirubicin—ovarian cancer	0.000234	0.00146	CcSEcCtD
Telaprevir—Loss of consciousness—Epirubicin—ovarian cancer	0.00023	0.00143	CcSEcCtD
Telaprevir—Asthenia—Docetaxel—ovarian cancer	0.000227	0.00141	CcSEcCtD
Telaprevir—Pruritus—Docetaxel—ovarian cancer	0.000224	0.00139	CcSEcCtD
Telaprevir—Anaemia—Doxorubicin—ovarian cancer	0.000223	0.00139	CcSEcCtD
Telaprevir—Nausea—Paclitaxel—ovarian cancer	0.000221	0.00138	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000221	0.00137	CcSEcCtD
Telaprevir—Syncope—Doxorubicin—ovarian cancer	0.000217	0.00135	CcSEcCtD
Telaprevir—Diarrhoea—Docetaxel—ovarian cancer	0.000216	0.00135	CcSEcCtD
Telaprevir—Loss of consciousness—Doxorubicin—ovarian cancer	0.000212	0.00132	CcSEcCtD
Telaprevir—Infection—Epirubicin—ovarian cancer	0.000212	0.00132	CcSEcCtD
Telaprevir—Shock—Epirubicin—ovarian cancer	0.00021	0.00131	CcSEcCtD
Telaprevir—Nervous system disorder—Epirubicin—ovarian cancer	0.000209	0.0013	CcSEcCtD
Telaprevir—Dizziness—Docetaxel—ovarian cancer	0.000209	0.0013	CcSEcCtD
Telaprevir—Thrombocytopenia—Epirubicin—ovarian cancer	0.000209	0.0013	CcSEcCtD
Telaprevir—Skin disorder—Epirubicin—ovarian cancer	0.000207	0.00129	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000204	0.00127	CcSEcCtD
Telaprevir—Vomiting—Docetaxel—ovarian cancer	0.000201	0.00125	CcSEcCtD
Telaprevir—Rash—Docetaxel—ovarian cancer	0.000199	0.00124	CcSEcCtD
Telaprevir—Dermatitis—Docetaxel—ovarian cancer	0.000199	0.00124	CcSEcCtD
Telaprevir—Infection—Doxorubicin—ovarian cancer	0.000196	0.00122	CcSEcCtD
Telaprevir—Shock—Doxorubicin—ovarian cancer	0.000194	0.00121	CcSEcCtD
Telaprevir—Nervous system disorder—Doxorubicin—ovarian cancer	0.000193	0.0012	CcSEcCtD
Telaprevir—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000193	0.0012	CcSEcCtD
Telaprevir—Skin disorder—Doxorubicin—ovarian cancer	0.000192	0.00119	CcSEcCtD
Telaprevir—Nausea—Docetaxel—ovarian cancer	0.000188	0.00117	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000184	0.00115	CcSEcCtD
Telaprevir—Fatigue—Epirubicin—ovarian cancer	0.000184	0.00114	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00017	0.00106	CcSEcCtD
Telaprevir—Fatigue—Doxorubicin—ovarian cancer	0.00017	0.00106	CcSEcCtD
Telaprevir—Urticaria—Epirubicin—ovarian cancer	0.000169	0.00105	CcSEcCtD
Telaprevir—Urticaria—Doxorubicin—ovarian cancer	0.000157	0.000975	CcSEcCtD
Telaprevir—Asthenia—Epirubicin—ovarian cancer	0.000153	0.000952	CcSEcCtD
Telaprevir—Pruritus—Epirubicin—ovarian cancer	0.000151	0.000939	CcSEcCtD
Telaprevir—Diarrhoea—Epirubicin—ovarian cancer	0.000146	0.000908	CcSEcCtD
Telaprevir—Asthenia—Doxorubicin—ovarian cancer	0.000142	0.000881	CcSEcCtD
Telaprevir—Dizziness—Epirubicin—ovarian cancer	0.000141	0.000877	CcSEcCtD
Telaprevir—Pruritus—Doxorubicin—ovarian cancer	0.00014	0.000869	CcSEcCtD
Telaprevir—Vomiting—Epirubicin—ovarian cancer	0.000136	0.000844	CcSEcCtD
Telaprevir—Diarrhoea—Doxorubicin—ovarian cancer	0.000135	0.00084	CcSEcCtD
Telaprevir—Rash—Epirubicin—ovarian cancer	0.000134	0.000837	CcSEcCtD
Telaprevir—Dermatitis—Epirubicin—ovarian cancer	0.000134	0.000836	CcSEcCtD
Telaprevir—Dizziness—Doxorubicin—ovarian cancer	0.00013	0.000812	CcSEcCtD
Telaprevir—Nausea—Epirubicin—ovarian cancer	0.000127	0.000788	CcSEcCtD
Telaprevir—Vomiting—Doxorubicin—ovarian cancer	0.000125	0.000781	CcSEcCtD
Telaprevir—Rash—Doxorubicin—ovarian cancer	0.000124	0.000774	CcSEcCtD
Telaprevir—Dermatitis—Doxorubicin—ovarian cancer	0.000124	0.000773	CcSEcCtD
Telaprevir—Nausea—Doxorubicin—ovarian cancer	0.000117	0.000729	CcSEcCtD
Telaprevir—CTSS—Innate Immune System—CDKN1B—ovarian cancer	8.35e-05	0.00112	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—NRAS—ovarian cancer	8.33e-05	0.00112	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—CDKN1B—ovarian cancer	8.02e-05	0.00108	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—NRAS—ovarian cancer	8e-05	0.00107	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—MAPK3—ovarian cancer	7.98e-05	0.00107	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—CTNNB1—ovarian cancer	7.89e-05	0.00106	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	7.84e-05	0.00105	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PTEN—ovarian cancer	7.69e-05	0.00103	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—MAPK1—ovarian cancer	7.59e-05	0.00102	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—EGFR—ovarian cancer	7.59e-05	0.00102	CbGpPWpGaD
Telaprevir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	7.57e-05	0.00102	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDH1—ovarian cancer	7.56e-05	0.00101	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	7.56e-05	0.00101	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	7.52e-05	0.00101	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.47e-05	0.001	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PTEN—ovarian cancer	7.38e-05	0.000991	CbGpPWpGaD
Telaprevir—CTSS—Immune System—TLR4—ovarian cancer	7.34e-05	0.000986	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	7.34e-05	0.000986	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—EGFR—ovarian cancer	7.29e-05	0.000979	CbGpPWpGaD
Telaprevir—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	7.26e-05	0.000975	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	7.25e-05	0.000973	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CD—ovarian cancer	7.22e-05	0.00097	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—KRAS—ovarian cancer	7.17e-05	0.000963	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TERT—ovarian cancer	7.07e-05	0.00095	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	7.07e-05	0.000949	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6ST—ovarian cancer	7.04e-05	0.000945	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	6.92e-05	0.000929	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—KRAS—ovarian cancer	6.89e-05	0.000924	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—NRAS—ovarian cancer	6.86e-05	0.000921	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	6.64e-05	0.000892	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	6.62e-05	0.000889	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—CASP3—ovarian cancer	6.62e-05	0.000889	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—IL2—ovarian cancer	6.61e-05	0.000888	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—NRAS—ovarian cancer	6.59e-05	0.000885	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—PIK3CA—ovarian cancer	6.59e-05	0.000884	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—MAPK3—ovarian cancer	6.57e-05	0.000882	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CAV1—ovarian cancer	6.54e-05	0.000878	CbGpPWpGaD
Telaprevir—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	6.53e-05	0.000877	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	6.49e-05	0.000871	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	6.43e-05	0.000863	CbGpPWpGaD
Telaprevir—CTSK—Immune System—ERBB2—ovarian cancer	6.38e-05	0.000856	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	6.35e-05	0.000852	CbGpPWpGaD
Telaprevir—ALB—Platelet degranulation—VEGFA—ovarian cancer	6.35e-05	0.000852	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—PIK3CA—ovarian cancer	6.33e-05	0.000849	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	6.32e-05	0.000848	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ESR1—ovarian cancer	6.3e-05	0.000846	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MTOR—ovarian cancer	6.29e-05	0.000845	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CB—ovarian cancer	6.29e-05	0.000845	CbGpPWpGaD
Telaprevir—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	6.29e-05	0.000845	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—MAPK1—ovarian cancer	6.25e-05	0.000839	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—EGFR—ovarian cancer	6.25e-05	0.000839	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDH1—ovarian cancer	6.23e-05	0.000836	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6ST—ovarian cancer	6.2e-05	0.000833	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—HRAS—ovarian cancer	6.09e-05	0.000818	CbGpPWpGaD
Telaprevir—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	6.05e-05	0.000812	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—EGFR—ovarian cancer	6e-05	0.000806	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—APC—ovarian cancer	5.96e-05	0.0008	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CG—ovarian cancer	5.96e-05	0.0008	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CD—ovarian cancer	5.95e-05	0.000798	CbGpPWpGaD
Telaprevir—ALB—Metabolism—NME2—ovarian cancer	5.91e-05	0.000793	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CDKN1B—ovarian cancer	5.91e-05	0.000793	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—KRAS—ovarian cancer	5.9e-05	0.000793	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—HRAS—ovarian cancer	5.85e-05	0.000786	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—IL6—ovarian cancer	5.83e-05	0.000783	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL2—ovarian cancer	5.78e-05	0.000776	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.73e-05	0.000769	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—KRAS—ovarian cancer	5.67e-05	0.000761	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	5.62e-05	0.000754	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—TP53—ovarian cancer	5.59e-05	0.000751	CbGpPWpGaD
Telaprevir—CTSK—Immune System—CTNNB1—ovarian cancer	5.58e-05	0.000749	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PTEN—ovarian cancer	5.44e-05	0.00073	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—PIK3CA—ovarian cancer	5.42e-05	0.000728	CbGpPWpGaD
Telaprevir—CTSK—Innate Immune System—AKT1—ovarian cancer	5.38e-05	0.000723	CbGpPWpGaD
Telaprevir—CTSS—Immune System—ERBB2—ovarian cancer	5.25e-05	0.000705	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CD—ovarian cancer	5.24e-05	0.000703	CbGpPWpGaD
Telaprevir—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	5.23e-05	0.000702	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—PIK3CA—ovarian cancer	5.21e-05	0.000699	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MTOR—ovarian cancer	5.18e-05	0.000696	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CB—ovarian cancer	5.18e-05	0.000696	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—NME2—ovarian cancer	5.18e-05	0.000695	CbGpPWpGaD
Telaprevir—CTSK—Adaptive Immune System—AKT1—ovarian cancer	5.17e-05	0.000694	CbGpPWpGaD
Telaprevir—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	5.16e-05	0.000693	CbGpPWpGaD
Telaprevir—ALB—Folate Metabolism—IL6—ovarian cancer	5.12e-05	0.000687	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—HRAS—ovarian cancer	5.02e-05	0.000674	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	5.02e-05	0.000674	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SPARC—ovarian cancer	5.01e-05	0.000673	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.01e-05	0.000673	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	4.9e-05	0.000658	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1B—ovarian cancer	4.86e-05	0.000653	CbGpPWpGaD
Telaprevir—CTSK—Immune System—STAT3—ovarian cancer	4.86e-05	0.000653	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—ovarian cancer	4.85e-05	0.000651	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—ovarian cancer	4.82e-05	0.000647	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6—ovarian cancer	4.8e-05	0.000645	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL2—ovarian cancer	4.76e-05	0.000639	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	4.71e-05	0.000632	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MAPK3—ovarian cancer	4.65e-05	0.000624	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	4.64e-05	0.000622	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—ovarian cancer	4.63e-05	0.000621	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—ovarian cancer	4.6e-05	0.000617	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CB—ovarian cancer	4.57e-05	0.000613	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MTOR—ovarian cancer	4.57e-05	0.000613	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTEN—ovarian cancer	4.48e-05	0.000601	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—AKT1—ovarian cancer	4.43e-05	0.000595	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MAPK1—ovarian cancer	4.42e-05	0.000594	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—ovarian cancer	4.42e-05	0.000594	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL8—ovarian cancer	4.39e-05	0.000589	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1B—ovarian cancer	4.28e-05	0.000575	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—AKT1—ovarian cancer	4.26e-05	0.000571	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CASP3—ovarian cancer	4.2e-05	0.000564	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL2—ovarian cancer	4.19e-05	0.000563	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—ovarian cancer	4.18e-05	0.000561	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	4.14e-05	0.000556	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	4.14e-05	0.000556	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—ovarian cancer	4.09e-05	0.000549	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.09e-05	0.000549	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	4.07e-05	0.000546	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—ovarian cancer	4.05e-05	0.000543	CbGpPWpGaD
Telaprevir—CTSS—Immune System—STAT3—ovarian cancer	4.01e-05	0.000538	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—ovarian cancer	4e-05	0.000536	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—ovarian cancer	3.97e-05	0.000533	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTEN—ovarian cancer	3.95e-05	0.00053	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—ovarian cancer	3.84e-05	0.000515	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MAPK3—ovarian cancer	3.83e-05	0.000514	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.82e-05	0.000513	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYTB—ovarian cancer	3.81e-05	0.000511	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.72e-05	0.0005	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.69e-05	0.000496	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SOD1—ovarian cancer	3.64e-05	0.000489	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MAPK1—ovarian cancer	3.64e-05	0.000489	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—ovarian cancer	3.64e-05	0.000489	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PPP2R1A—ovarian cancer	3.63e-05	0.000487	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	3.61e-05	0.000484	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	3.6e-05	0.000483	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—ovarian cancer	3.56e-05	0.000478	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—ovarian cancer	3.55e-05	0.000477	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STAT3—ovarian cancer	3.53e-05	0.000474	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—ovarian cancer	3.52e-05	0.000473	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—ovarian cancer	3.44e-05	0.000462	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—ovarian cancer	3.4e-05	0.000456	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK3—ovarian cancer	3.37e-05	0.000453	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.35e-05	0.00045	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYTB—ovarian cancer	3.34e-05	0.000448	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	3.33e-05	0.000448	CbGpPWpGaD
Telaprevir—ALB—Metabolism—BRIP1—ovarian cancer	3.33e-05	0.000447	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPP1CC—ovarian cancer	3.33e-05	0.000447	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	3.31e-05	0.000445	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—ovarian cancer	3.28e-05	0.00044	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	3.27e-05	0.000439	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.23e-05	0.000434	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK1—ovarian cancer	3.21e-05	0.000431	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—ovarian cancer	3.21e-05	0.000431	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—NME2—ovarian cancer	3.19e-05	0.000428	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	3.18e-05	0.000427	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—ovarian cancer	3.16e-05	0.000424	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	3.15e-05	0.000423	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—ovarian cancer	3.13e-05	0.000421	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	3.07e-05	0.000412	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—ovarian cancer	3.03e-05	0.000407	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—ovarian cancer	2.92e-05	0.000392	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPP1CC—ovarian cancer	2.92e-05	0.000392	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—BRIP1—ovarian cancer	2.92e-05	0.000392	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.91e-05	0.000391	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	2.82e-05	0.000378	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—ovarian cancer	2.8e-05	0.000376	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—ovarian cancer	2.78e-05	0.000374	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	2.77e-05	0.000372	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—ovarian cancer	2.69e-05	0.000362	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CAV1—ovarian cancer	2.66e-05	0.000358	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	2.66e-05	0.000358	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	2.62e-05	0.000352	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—ovarian cancer	2.58e-05	0.000347	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—ovarian cancer	2.58e-05	0.000346	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	2.55e-05	0.000342	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	2.53e-05	0.00034	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	2.5e-05	0.000335	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	2.49e-05	0.000335	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—ovarian cancer	2.46e-05	0.000331	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CG—ovarian cancer	2.43e-05	0.000326	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.43e-05	0.000326	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	2.36e-05	0.000316	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—ovarian cancer	2.27e-05	0.000305	CbGpPWpGaD
Telaprevir—ALB—Metabolism—YAP1—ovarian cancer	2.23e-05	0.0003	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.21e-05	0.000297	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	2.2e-05	0.000295	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	2.17e-05	0.000291	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CD—ovarian cancer	2.13e-05	0.000286	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	2.09e-05	0.000281	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYTB—ovarian cancer	2.06e-05	0.000276	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—YAP1—ovarian cancer	1.96e-05	0.000263	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.94e-05	0.000261	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CB—ovarian cancer	1.86e-05	0.00025	CbGpPWpGaD
Telaprevir—ALB—Metabolism—FASN—ovarian cancer	1.82e-05	0.000244	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.8e-05	0.000241	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.8e-05	0.000241	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.8e-05	0.000241	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC5A5—ovarian cancer	1.79e-05	0.00024	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.77e-05	0.000237	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC2A1—ovarian cancer	1.73e-05	0.000232	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—ovarian cancer	1.71e-05	0.000229	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.69e-05	0.000227	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1B1—ovarian cancer	1.66e-05	0.000223	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—FASN—ovarian cancer	1.59e-05	0.000214	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.57e-05	0.000211	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.51e-05	0.000203	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPP2R1A—ovarian cancer	1.47e-05	0.000197	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.46e-05	0.000196	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.45e-05	0.000195	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—ovarian cancer	1.45e-05	0.000195	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—ovarian cancer	1.43e-05	0.000192	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK3—ovarian cancer	1.37e-05	0.000184	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—ovarian cancer	1.36e-05	0.000183	CbGpPWpGaD
Telaprevir—ALB—Metabolism—TYMS—ovarian cancer	1.34e-05	0.00018	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK1—ovarian cancer	1.31e-05	0.000175	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.29e-05	0.000173	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—ovarian cancer	1.23e-05	0.000166	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—YAP1—ovarian cancer	1.21e-05	0.000162	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—TYMS—ovarian cancer	1.17e-05	0.000158	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—ovarian cancer	1.13e-05	0.000152	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—ovarian cancer	1.1e-05	0.000147	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CAV1—ovarian cancer	1.08e-05	0.000145	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—ovarian cancer	1.05e-05	0.000141	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.03e-05	0.000139	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CG—ovarian cancer	9.84e-06	0.000132	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FASN—ovarian cancer	9.82e-06	0.000132	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A5—ovarian cancer	9.66e-06	0.00013	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CAV1—ovarian cancer	9.46e-06	0.000127	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC2A1—ovarian cancer	9.33e-06	0.000125	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—ovarian cancer	9.26e-06	0.000124	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1B1—ovarian cancer	8.95e-06	0.00012	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CD—ovarian cancer	8.65e-06	0.000116	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CG—ovarian cancer	8.62e-06	0.000116	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	7.94e-06	0.000107	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CD—ovarian cancer	7.58e-06	0.000102	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CB—ovarian cancer	7.54e-06	0.000101	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—ovarian cancer	7.37e-06	9.89e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—TYMS—ovarian cancer	7.24e-06	9.72e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CB—ovarian cancer	6.61e-06	8.87e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—ovarian cancer	6.51e-06	8.75e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CAV1—ovarian cancer	5.83e-06	7.83e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—ovarian cancer	5.71e-06	7.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.31e-06	7.13e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.67e-06	6.27e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—ovarian cancer	4.6e-06	6.17e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.07e-06	5.46e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—ovarian cancer	4.03e-06	5.41e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—ovarian cancer	3.75e-06	5.04e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—ovarian cancer	3.52e-06	4.72e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—ovarian cancer	3.29e-06	4.42e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.48e-06	3.33e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—ovarian cancer	2.03e-06	2.72e-05	CbGpPWpGaD
